Moderna will be the main vaccine administered over coming weeks to over-60s, over-50s, healthcare workers and younger people in vulnerable groups

‘It was like a tap being turned on from Thursday or Friday last week. It’s been mostly young people’

Johnson unveils ‘temporary and precautionary’ Covid restrictions to slow variant

Tablet has potential to avoid nine of 10 hospitalisations with virus, says pharma giant

Company to submit application for US authorisation by end of the year

Company has filed for regulatory authorisation for shot in India, Indonesia, Philippines

World wrap: Sydney lockdown could last months as daily cases reach record high

US vaccination take-up rates are slowing, as Novavax jab on course for autumn approval

CEO expects early supplies to be used for Covax supplies as analysts eye shot as booster option

Company is talking to governments about creating vaccine manufacturing facilities

Vaccine-makers drop on Wall Street after Biden backs intellectual property waivers

Ireland is in line for up to 2.2m doses of company’s vaccine supply from late-2021

Explainer: The best vaccine is the one that you are offered, say public-health doctors

Oxford scientists test vaccine combinations amid concern over rare side effects

Serum institute is biggest supplier to the international Covax programme

Firm facing complaints over delivery pledges but also reports of possible side effects

EU hoping to buy up to 200m Novavax vaccines

Company to deliver 200m doses to EU with 600,000 to Republic between April and June

EU has deal with company for millions of doses

Daily updates as Ireland embarks on largest inoculation programme in its history